Using routinely acquired pathology slides, the model accurately predicts the origin of cancers with unknown primary tumors. In 1 to 2 percent of cancer cases, the primary site of tumor origin cannot be determined. Because many modern cancer therapeutics target primary tumors, the prognosis for a cancer of unknown primary (CUP) is poor, with a...
